A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma

Emilian Racila, Brian K. Link, Wen Kai Weng, Thomas E. Witzig, Stephen Ansell, Matthew J. Maurer, Jian Huang, Christopher Dahle, Ahmad Halwani, Ronald Levy, George J. Werner

Research output: Contribution to journal › Article › peer-review

119 Scopus citations

Fingerprint

Dive into the research topics of 'A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences